212 results
Page 2 of 11
UPLOAD
cmetayyf25fvw9
6 Sep 23
Letter from SEC
12:00am
SC TO-T/A
EX-99
3e3u2d7qf6gcgput y9
9 Aug 23
Third party tender offer statement (amended)
9:14am
8-K
EX-99.1
tezxpb13z n3noe
8 Aug 23
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements
7:01am
SC TO-T/A
EX-99
3e0oiz qlh
25 Jul 23
Third party tender offer statement (amended)
7:04am
SC TO-C
EX-99.1
o5fgx6khji5rb7z7get3
29 Jun 23
Information about tender offer
6:56am
SC TO-C
EX-99.1
o6bqnjd4bvahwd
20 Jun 23
Information about tender offer
8:20am
8-K
EX-99.01
qj3iaxata44uuxi
27 Apr 23
Results of Operations and Financial Condition
7:02am
PX14A6G
o786yo78
10 Apr 23
Letter to shareholders
4:51pm
PX14A6G
4an1n1kvo4wqvw q6kuc
4 Apr 23
Letter to shareholders
3:57pm
8-K
EX-99
hxt2zeu xsr38w2nh
13 Dec 22
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
7:03am
SC TO-T/A
EX-99
yomrw
30 Nov 22
Third party tender offer statement (amended)
6:58am
8-K
EX-99.1
g28nrf
1 Nov 22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
7:03am
SC TO-C
EX-99.1
3s98s ashvk
18 Oct 22
Information about tender offer
7:02am
8-K
EX-99.1
khcg7q7curaee mh
4 Aug 22
Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines and Pipeline Advancements
7:05am
8-K
EX-99
9q3ek5
6 May 22
Mary Lynne Hedley Elected to Lilly Board of Directors
4:23pm